insights_auto
Kwa nini EDIT imeongezeka kwa 7.23%?
Fahamu zaidichevron_right
EDIT:NASDAQ
Editas Medicine Inc
US$ 2.60
arrow_upward
+7.23%(+0.17) Siku 1
20 Okt, 12:17:05 GMT -4 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya EDIT...
Fungua
US$ 2.40
Juu
US$ 2.63
Chini
US$ 2.35
Mtaji wa soko
398.54M
Wastani wa kiasi cha mauzo
3.03M
Kiasi cha mauzo ya hisa
elfu 862.10
Juu kwa wiki 52
US$ 4.21
Chini kwa wiki 52
US$ 1.66
EPS
-US$ 0.74
Beta
2.00
Hisa za wawekezaji
153.58M
Idadi ya wafanyakazi
87
Fungua
US$ 2.40
Juu
US$ 2.63
Chini
US$ 2.35
Mtaji wa soko
398.54M
Wastani wa kiasi cha mauzo
3.03M
Kiasi cha mauzo ya hisa
elfu 862.10
Juu kwa wiki 52
US$ 4.21
Chini kwa wiki 52
US$ 1.66
EPS
-US$ 0.74
Beta
2.00
Hisa za wawekezaji
153.58M
Idadi ya wafanyakazi
87
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Foreign Policy Journal
·
dakika 6 zilizopita
Super Micro Computer (NASDAQ: SMCI) Lands Over $60 Billion In Orders As Legal Clouds Raise Discount Questions
Benzinga
·
saa 1 iliyopita
Quantum BioPharma (NASDAQ: QNTM) Featured in Men’s Fitness Article Examining Unbuzzd Clinical Trial Resul
Yahoo Finance
·
dakika 20 zilizopita
Unpacking Q2 Earnings: Zoom (NASDAQ:ZM) In The Context Of Other Video Conferencing Stocks
Seeking Alpha
·
dakika 43 zilizopita
Energy Stocks Lead This Year, But Tech Still Drives The S&P 500
Wasifu
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
Kuhusu Editas Medicine Inc
Afisa Mkuu Mtendaji (CEO)-
Wafanyakazi87
LilianzishwaNov 2013
Makao makuu-
Sekta-
Tovutieditasmedicine.com